arrow
V

Víctor A. Arrieta

northwestern university
H指数:18
被引数:1,640

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Multi-Omic Profiling of Human Peritumoral Brain Following Ultrasound-Mediated BBB Disruption Reveals Microglial Reprogramming and Enhanced Endothelial Crosstalk

超声介导的血脑屏障破坏后的人体肿瘤周围脑组织的多组学分析揭示了小胶质细胞的重新编程和增强的血管内皮细胞互作

2025-11-010
OAAI
YBX1&YBX3 as novel targets to potentiate immune checkpoint blockade response in gliomas

YBX1&YBX3作为增强胶质瘤免疫检查点阻断反应的新型靶点

2025-11-010
PRE
Spatial Immunophenotypic Characterization of Immune Exclusion and Dysfunction via Collagen-Rich Fibrous Septa in Chordomas

通过富含胶原的纤维性间隔对脊索瘤中免疫排斥和功能障碍的空间免疫表型表征

2025-11-010
OAAI
Focused ultrasound-mediated blood-brain barrier disruption, combined with antigen-presenting cell activation, promotes CNS antigen-specific T cell immunity and bypasses immunotherapy resistance mechanism in malignant brain tumors

聚焦超声介导的血脑屏障破坏,结合抗原提呈细胞激活,促进中枢神经系统抗原特异性T细胞免疫,并绕过恶性脑肿瘤的免疫疗法耐药机制。

2025-11-010
OAAI
Targeting TGFβ-mediated B cell suppression enhances anti-PD-1 efficacy in glioblastoma

靶向TGFβ介导的B细胞抑制可增强胶质母细胞瘤中抗PD-1的疗效

2025-11-010
OAAI
Dual aVß8 Integrin and PD-1 Blockade Overcomes TGFβ-Mediated B-Cell Suppression to Enhance Anti-Tumor Immunity

双aVß8整合素和PD-1阻断克服TGFβ介导的B细胞抑制以增强抗肿瘤免疫

2025-06-011
PRE
Endothelial response to blood-brain barrier disruption in the human brain
2024-12-260
OA
PHARMACOKINETIC ANALYSIS OF CARBOPLATIN AND FLUORESCEIN BRAIN PENETRATION AND PERMANENCE FOLLOWING ULTRASOUND-BASED BLOOD-BRAIN BARRIER OPENING ON GLIOBLASTOMA CLINICAL TRIAL
2024-11-110
PRE
B-CELL BASED THERAPY (BVAX) PRODUCES ANTIBODIES TO SUPPRESS GLIOBLASTOMA TUMOR MIGRATION AND INVASION
2024-11-110
PRE
LOW-INTENSITY PULSED ULTRASOUND COMBINED WITH POLY-ICLC AND INTERLEUKIN-2 UNLOCKS THE IMMUNE PRIVILEGE OF THE BRAIN BY PROMOTING EPITOPE SPREADING AND ACTIVATION OF CNS-SPECIFIC NAÏVE T CELLS

低强度脉冲超声联合poly-iclc和INTERLEUKIN-2通过促进CNS特异性初始T细胞的表位扩散和激活来解锁大脑的免疫特权

2024-11-110
PRE
T-CELL THERAPY COMBINED WITH LOW-INTENSITY PULSED FOCUSED ULTRASOUND, MICROBUBBLES AND POLY-ICLC PROMOTES THE PRESENTATION OF BRAIN-DERIVED ANTIGENS, BREAKING CNS TOLERANCE AND INDUCING ACTIVE T-CELL RESPONSES
2024-10-170
PRE
B cell-based therapy produces antibodies that inhibit glioblastoma growth
2024-08-290
OAAI
Fc-enhanced anti-CTLA-4, anti-PD-1, doxorubicin, and ultrasound-mediated blood-brain barrier opening: A novel combinatorial immunotherapy regimen for gliomas
2024-07-191
PRE
Ultrasound-mediated delivery of doxorubicin to the brain results in immune modulation and improved responses to PD-1 blockade in gliomas
2024-06-0612
OAAI
Low-intensity pulsed ultrasound enhances the presentation of brain-derived antigens by facilitating the migration of antigen-presenting cells from the brain to the periphery
2024-03-220
PRE
The CXCL16-CXCR6 axis in glioblastoma modulates T-cell activity in a spatiotemporal context
2024-01-173
OAAI
Antigen-presenting B cells promote TCF-1+ PD1- stem-like CD8+ T-cell proliferation in glioblastoma
2024-01-105
OAAI